Dr. Clark allegedly bought controlled substances for purposes unrelated to his profession and then kept and dealt the ...

Recovery Centers of America pays $2 million to settle allegations of mismanaging controlled substances and subpar treatment ...

The rally marked one of the biggest single-day moves for cannabis stocks in years, snapping a prolonged slump.

Trump's decision to move marijuana to Schedule III could ease taxes and expand medical access, but industry leaders warn it ...

What began as a string of undercover drug buys in the northwest suburbs has ended with a 31-year-old Des Plaines man sitting ...

The organization agrees to pay $2M after federal officials allege violations of the controlled substance laws and false ...

President Trump is considering signing an executive order that would reschedule cannabis as a Schedule III drug. That's a bad ...

Cannabis ETFs post record weekly gains as Trump plans to reclassify marijuana as a less dangerous drug, signaling major ...

Cannabis stock extended premarket gains as President Donald Trump is expected to sign an executive order on marijuana ...

President Donald Trump is expected to push for marijuana reclassification from Schedule I to Schedule III status, sending ...

Bipartisan congressional lawmakers are weighing in on a potentially imminent decision by President Donald Trump to move ...